Olpha
Olaine, Latvia
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Olpha
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Olaine, Latvia
- Website
- https://olpha.eu/en/
- Modalities
- Oral Solid Dose, Small Molecule API, Intermediates
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Olpha
Olpha makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Oral Solid Dose, Small Molecule API, Intermediates. 1 manufacturing site registered with the U.S. FDA. Website: https://olpha.eu/en/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Frequently Asked Questions About Olpha
Does Olpha have a CDMO Signal Score?
Not yet. Olpha is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Olpha for a manufacturing program?
Use the free AI matchmaker to compare Olpha against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Shanghai Desano
Shanghai, China
Small Molecule API, Intermediates, Oral Solid Dose, Oligonucleotide
PharmaBlock
Nanjing, Jiangsu, China
Small Molecule API, Intermediates, Oral Solid Dose
Viwit Pharmaceutical
Zaozhuang, Shandong, China
Small Molecule API, Intermediates, Oral Solid Dose, Sterile Injectables
Zenji Pharmaceuticals
Huai'an, Jiangsu, China
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose
Compare Olpha with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.